stockrowPulse Biosciences, Inc
PLSE Healthcare Medical Instruments & Supplies
Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.
- Revenue
- +359.3%
- EPS
- −10.3%
- Free cash flow
- −1,180.5%
Quarter to September 2026, against a year earlier
Follow PLSE
Alert me
Pulse Biosciences, Inc (PLSE) EBITDA
Pulse Biosciences, Inc's EBITDA for fiscal 2025 was −$75.9M, compared with −$55.1M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$82.0M. Over the past ten years it has ranged from −$75.9M (fiscal 2025) to −$3.8M (fiscal 2015) — the current reading is the lowest in ten years. Pulse Biosciences, Inc ranks 46th of 47 Medical Instruments & Supplies companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | −$75.9M | — |
| FY2024 | −$55.1M | — |
| FY2023 | −$42.4M | — |
| FY2022 | −$56.7M | — |
| FY2021 | −$61.9M | — |
| FY2020 | −$48.9M | — |
| FY2019 | −$47.3M | — |
| FY2018 | −$36.8M | — |
| FY2017 | −$24.8M | — |
| FY2016 | −$8.8M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | −$25.0M | — |
| Mar 2026 | −$18.9M | — |
| Dec 2025 | −$18.0M | — |
| Sep 2025 | −$20.1M | — |
| 42 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| NVST Envista Holdings Corporation compare | $428.9M |
| MMSI Merit Medical Systems, Inc. compare | $359.6M |
| STVN Stevanato Group S.p.A. compare | $351.1M |
| ICUI ICU Medical, Inc. compare | $314.2M |
| TFX Teleflex Incorporated compare | $256.2M |
| WRBY Warby Parker Inc. compare | $59.0M |
| ATRC AtriCure, Inc. compare | $34.2M |
| MMED MiniMed Group, Inc. compare | −$8.0M |
| PLSE Pulse Biosciences, Inc | −$82.0M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on PLSE
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Altman Z-score
- The full statement